# A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus

> **NCT01792635** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 19 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** PF-05175157
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01792635
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** The study was terminated prematurely on 16 May 2014 due to a safety concern.
- **Last updated:** 2017-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01792635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01792635, "A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01792635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*